Shuji Maekawa

Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan

Ikuya Miki, Nobuo Aoyama, Toshiyuki Sakai et al. · European Journal of Gastroenterology & Hepatology · 2003 · 72 citations

Medicine, Pharmacology, Pharmacotherapy +15

Effect of Helicobacter pylori‐Induced Cyclooxygenase‐2 on Gastric Epithelial Cell Kinetics: Implication for Gastric Carcinogenesis

Casmir Wambura, Nobuo Aoyama, Daisuke Shirasaka et al. · Helicobacter · 2002 · 37 citations · Full text

Medicine, Oncology, Pathobiology +15

Leukocytapheresis therapy for steroid‐naïve patients with active ulcerative colitis: Its clinical efficacy and adverse effects compared with those of conventional steroid therapy

Chiharu Nishioka, Nobuo Aoyama, Shuji Maekawa et al. · Journal of Gastroenterology and Hepatology · 2005 · 31 citations

Pharmacy, Immunology, Pharmacotherapy +13

Influence of Paired Mn²⁺ Centers on the Luminescence Spectra of CaS:Mn²⁺

Nobuhiko Yamashita, Shuji Maekawa, Kaizo Nakamura · Japanese Journal of Applied Physics · 1990 · 27 citations

Natural Sciences, Chemistry, Materials Science +14

HLA‐DQB1 locus and gastric cancer in <i>Helicobacter pylori</i> infection

Yoshinori Watanabe, Nobuo Aoyama, Toshiyuki Sakai et al. · Journal of Gastroenterology and Hepatology · 2006 · 22 citations · Full text

Medicine, Immunology, Pathology +17